These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

527 related items for PubMed ID: 19527759

  • 1. Clinical significance of anti-HLA antibodies detected by Luminex: enhancing the interpretation of CDC-BXM and important post-transplantation monitoring tools.
    Eng HS, Bennett G, Bardy P, Coghlan P, Russ GR, Coates PT.
    Hum Immunol; 2009 Aug; 70(8):595-9. PubMed ID: 19527759
    [Abstract] [Full Text] [Related]

  • 2. Reappraisal of HLA antibody analysis and crossmatching in kidney transplantation.
    Lee PC, Ozawa M.
    Clin Transpl; 2007 Aug; ():219-26. PubMed ID: 18642453
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Relevance of different antibody detection methods for the prediction of antibody-mediated rejection and deceased-donor kidney allograft survival.
    Vlad G, Ho EK, Vasilescu ER, Colovai AI, Stokes MB, Markowitz GS, D'Agati VD, Cohen DJ, Ratner LE, Suciu-Foca N.
    Hum Immunol; 2009 Aug; 70(8):589-94. PubMed ID: 19375470
    [Abstract] [Full Text] [Related]

  • 5. Detection of donor-specific antibodies using HLA-coated microspheres: another tool for kidney transplant risk stratification.
    Gibney EM, Cagle LR, Freed B, Warnell SE, Chan L, Wiseman AC.
    Nephrol Dial Transplant; 2006 Sep; 21(9):2625-9. PubMed ID: 16644776
    [Abstract] [Full Text] [Related]

  • 6. Clinical relevance of complement-fixing antibodies in cardiac transplantation.
    Rose ML, Smith JD.
    Hum Immunol; 2009 Aug; 70(8):605-9. PubMed ID: 19375471
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Consensus guidelines on the testing and clinical management issues associated with HLA and non-HLA antibodies in transplantation.
    Tait BD, Süsal C, Gebel HM, Nickerson PW, Zachary AA, Claas FH, Reed EF, Bray RA, Campbell P, Chapman JR, Coates PT, Colvin RB, Cozzi E, Doxiadis II, Fuggle SV, Gill J, Glotz D, Lachmann N, Mohanakumar T, Suciu-Foca N, Sumitran-Holgersson S, Tanabe K, Taylor CJ, Tyan DB, Webster A, Zeevi A, Opelz G.
    Transplantation; 2013 Jan 15; 95(1):19-47. PubMed ID: 23238534
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Clinical relevance of pretransplant human leukocyte antigen donor-specific antibodies in renal patients waiting for a transplant: a risk factor.
    Gupta A, Sinnott P.
    Hum Immunol; 2009 Aug 15; 70(8):618-22. PubMed ID: 19374932
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Back to the future: application of contemporary technology to long-standing questions about the clinical relevance of human leukocyte antigen-specific alloantibodies in renal transplantation.
    Taylor CJ, Kosmoliaptsis V, Summers DM, Bradley JA.
    Hum Immunol; 2009 Aug 15; 70(8):563-8. PubMed ID: 19445992
    [Abstract] [Full Text] [Related]

  • 16. Impact of alloantibody strength in crossmatch negative DSA positive kidney transplantation.
    Wu P, Jin J, Everly MJ, Lin C, Terasaki PI, Chen J.
    Clin Biochem; 2013 Oct 15; 46(15):1389-93. PubMed ID: 23726814
    [Abstract] [Full Text] [Related]

  • 17. The acceptable reactive crossmatch (ARC), post-transplant monitoring, and their impact on kidney transplantation: a single center experience.
    Leone JP, Bowers V, Baliga R, Sanders C, LeFor W, Becker D, Thompson D, Resto-Ruiz S, Lopez-Cepero M.
    Clin Transpl; 2011 Oct 15; ():373-9. PubMed ID: 22755434
    [Abstract] [Full Text] [Related]

  • 18. Pre-transplant donor specific antibody and its clinical significance in kidney transplantation.
    Thammanichanond D, Ingsathit A, Mongkolsuk T, Rattanasiri S, Kantachuvesiri S, Sakhonrat C, Leenanupan C, Worawichawongs S, Kitpoka P.
    Asian Pac J Allergy Immunol; 2012 Mar 15; 30(1):48-54. PubMed ID: 22523907
    [Abstract] [Full Text] [Related]

  • 19. Donor human leukocyte antigen specific antibodies predict development and define prognosis in transplant glomerulopathy.
    Eng HS, Bennett G, Chang SH, Dent H, McDonald SP, Bardy P, Coghlan P, Russ GR, Coates PT.
    Hum Immunol; 2011 May 15; 72(5):386-91. PubMed ID: 21320562
    [Abstract] [Full Text] [Related]

  • 20. Clinical relevance of anti-HLA donor-specific antibodies detected by Luminex assay in the development of rejection after renal transplantation.
    Caro-Oleas JL, González-Escribano MF, Gentil-Govantes MÁ, Acevedo MJ, González-Roncero FM, Blanco GB, Núñez-Roldán A.
    Transplantation; 2012 Aug 27; 94(4):338-44. PubMed ID: 22814330
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.